TrialThe Journal of international medical research2019

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.

Amarnath Challapalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.